Entering text into the input field will update the search result below

Buy the dip on AMAG, says Summer Street

Jan. 22, 2014 10:40 AM ETAMAG Pharmaceuticals, Inc. (AMAG) StockAMAGBy: Stephen Alpher, SA News Editor
  • Remember, says analyst Carol Werther, AMAG has  $214M in cash and revenues of $80M in 2013. At $22 per share, enterprise value is $261M, or just over 3x revenue. The company was also cash flow positive the last two quarters. Her team would be aggressive buyers at $17.
  • The stock is now off 7.4% to $20.24.
  • Previous: AMAG gets a CRL from the FDA on Feraheme

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
AMAG--
AMAG Pharmaceuticals, Inc.